1. Home
  2. THRY vs HUMA Comparison

THRY vs HUMA Comparison

Compare THRY & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

BUY

Current Price

$1.15

Market Cap

179.6M

Sector

Industrials

ML Signal

BUY

Logo Humacyte Inc.

HUMA

Humacyte Inc.

BUY

Current Price

$0.40

Market Cap

165.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
THRY
HUMA
Founded
2012
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.6M
165.7M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
THRY
HUMA
Price
$1.15
$0.40
Analyst Decision
Hold
Buy
Analyst Count
4
5
Target Price
★ $4.00
$1.63
AVG Volume (30 Days)
541.4K
★ 5.7M
Earning Date
10-29-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.50
79.37
EPS
N/A
★ N/A
Revenue
★ $785,015,000.00
$2,038,000.00
Revenue This Year
N/A
$72.32
Revenue Next Year
N/A
$518.79
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.18
$0.34
52 Week High
$12.57
$1.80

Technical Indicators

Market Signals
Indicator
THRY
HUMA
Relative Strength Index (RSI) 21.60 34.40
Support Level N/A N/A
Resistance Level $4.22 $0.75
Average True Range (ATR) 0.09 0.04
MACD -0.01 -0.00
Stochastic Oscillator 3.12 30.48

Price Performance

Historical Comparison
THRY
HUMA

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: